Arcus Biosciences Announces New Employment Inducement Grants
Arcus Biosciences granted three new employees options to purchase 10,650 shares at $18.54 plus RSUs covering 5,350 shares, under its 2020 Inducement Plan. The awards were made under the NYSE inducement exception (Rule 303A.08), meaning they sit outside the shareholder-approved equity plan and reflect standard new-hire compensation.
Key figures
- Employees granted
- 3
- Rsu shares granted
- 5350
- Option exercise price
- 18.54
- Option shares granted
- 10650
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.